Log in to save to my catalogue

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommenda...

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommenda...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cc82507f39374d3db578fbdc6f86db71

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

About this item

Full title

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2020-07, Vol.18 (1), p.215-14, Article 215

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The novel coronavirus pandemic calls for a rapid adaptation of conventional medical practices to meet the evolving needs of such vulnerable patients. People with coronavirus disease (COVID-19) may frequently require treatment with psychotropic medications, but are at the same time at higher risk for safety issues because of the complex underlying m...

Alternative Titles

Full title

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cc82507f39374d3db578fbdc6f86db71

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cc82507f39374d3db578fbdc6f86db71

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-020-01685-9

How to access this item